Peter Andersen

Critic
DISC Type : C

Chief Research & Development Officer at TreeFrog Therapeutics

United States

Overview

As Chief Research & Development Officer at Treefrog Therapeutics, Peter Andersen is an executive leader focused on translating scientific innovation into therapies. His expertise covers regenerative medicine and cell & gene therapy, built upon a PhD from The Johns Hopkins University School of Medicine and a career in academia and industry.


He is a named inventor on patents for methods related to producing muscle stem cells and inducing heart muscle cell proliferation.

Personality Overview

Precise

Information Seeker

Critic

They like to take decisions independently and do not seek others' support often.  It is very likely that they will negotiate pricing or other important terms. Unless the value is proven by data, they are unlikely to value fancy features.

Topics They Care About

Cell Therapy Manufacturing
He is a keynote speaker on Treefrog's C-Stem platform, a technology for mass-producing cell therapies, and is focused on driving innovation in this area.
Regenerative Medicine
His career is dedicated to this field, with deep expertise in using stem cells to address critical unmet medical needs.
Biotech Start-ups
As a founder, investor, and board member for companies like Jellatech, he is passionate about advising and growing early-stage biotech ventures.

Media Appearances

Peter has no verified media appearances

Work History

7-2024
Chief Research & Development Officer at TreeFrog Therapeutics
6-2023
Member Board of Directors at Jellatech
6-2022
Adjunct Professor at The Johns Hopkins University School of Medicine
6-2021
Investor and member of the byFounders collective at byFounders
7-2019 - 6-2022
Assistant Professor at The Johns Hopkins University School of Medicine

Education

6-2016 - 6-2016
Doctor of Philosophy - PhD from The Johns Hopkins University School of Medicine
2007 - 2010
PhD from Københavns Universitet - University of Copenhagen

More Information

Social Presence :

Prographics :

Exp : 7 Location : United States Job Level : Leadership Designation : Chief Research & Development Officer at TreeFrog Therapeutics
URL has been copied!

Insights For Selling To Peter

During A Call Or A Meeting

DO's

  • If you can, show them industry reports or analyst comments instead of sharing anecdotal stories
  • Be formal and objective, they will appreciate it more
  • Don’t forget to mention how you compare to competition on both features and pricing

DONT's

  • Don’t try to give too many examples of other users, they like to make their own decisions
  • Avoid pushing them too much to involve other stakeholders unless it is critical
  • Don’t rush them till they have clearly gotten all the necessary information

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Peter is

  • Proof of ROI, low pricing and objective proof points are the important factors for them.
  • Will you ever get a clear answer from Peter

  • They do not mind saying no if they believe that it is the right decision.

Insights For Deal Planning

    How fast (or slow) will Peter move?

  • Their decision-making is neither very fast nor very slow, they are somewhere in between.
  • Can Peter take some risk or not?

  • They can take risks if their analysis shows that it would be worth it.

You And Peter

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.